Recombinant Human IGFBP5

• Description:

  An IGF-binding protein, IBP-5 is produced by fibroblasts, myoblasts, osteoblasts and vascular smooth muscle cells. IBP-5 has been shown to specifically inhibit breast cancer cell growth by inducing apoptosis. IBP-5 contains an IGFBP domain and a thyroglobulin type-1 domain.

• Gene Name:

  IGFBP5

• Gene Aliases:

  IBP-5, IGF-binding protein 5, IGFBP-5, IGF-BP5
  Recombinant Human Insulin-Like Growth Factor Binding Protein 5 (IGFBP5)

• Gene ID:

  3488

• Accession Number:

  P24593

• Organism:

  Human

• Source:

  E. coli

• Concentration:

  <1.0 EU/μg of recombinant protein as determined by the LAL method.

• Purity:

  >95% as determined by SDS-PAGE

• Solubility:

  A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

• Function:

  N.A.

• Molecular Weight:

  26.5

• Shipping Conditions:

  Ambient Temperature

• Storage Conditions:

  The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.

• Appearance:

  Lyophilized Powder

• Formulation:

  Lyophilized from a 0.2 μm filtered solution of 10mM sodium Citrate pH 3.0

• CAS Number:

  9000-83-3